Research Article
Identification of Key Differentially Expressed Transcription Factors in Glioblastoma
Figure 5
Validation of aberrant expression and survival analysis. (a) The aberrant expression of the six key differentially expressed transcription factors was validated by combining the brain gene expression profile from Genotype-Tissue Expression database and The Cancer Genome Atlas in paracancer tissues. The asterisk indicates . (b) High expression of EN1 was associated with shorter overall survival of GBM patients. (c) High expression of EGR3 was associated with shorter recurrence-free survival of GBM patients.
(a) |
(b) |
(c) |